Cathepsin cysteine protease inhibitors
US6835727B2 · kind B2 · utility
12Cited by
1References
16Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 23, 2002 |
| Grant date | Dec 28, 2004 |
| Priority date | — |
| Expiry date | Dec 25, 2022 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention relates to a novel class of compounds which are cysteine protease inhibitors, including but not limited to, inhibitors of Cathepsins K and L. These compounds are useful for treating diseases in which inhibition of bone resorption is indicated, such as osteoporosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.